[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369886-105":59,"doc-detail-369886-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","metabolic-profiles-of-squamous-cell-lung-carcinoma-and-diagnostic-model-construction","Metabolic profiles of squamous cell lung carcinoma and diagnostic model construction","","Metabolic profiles of squamous cell lung carcinoma (LUSC) were investigated to understand cancer cell metabolic reprogramming tied to abnormal growth and proliferation. Elevated arginine and reduced acylcarnitine C18:2, together with decreased phosphatidylcholine (PC) carrying acyl-alkyl residues C38:0, were linked to diagnosis and prognosis. Most PCs decreased while lysophosphatidylcholines (LPCs) increased in LUSC patients. Network and public-data analyses connected LPC-mediated interactions with PC and amino acids and associated pathway gene expression with 5-year survival, supporting metabolites as potential supportive biomarkers for LUSC.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/metabolic-profiles-of-squamous-cell-lung-carcinoma-and-diagnostic-model-construction/369886/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/metabolic-profiles-of-squamous-cell-lung-carcinoma-and-diagnostic-model-construction/369886.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Which metabolites were associated with LUSC diagnosis and prognosis?","Question",{"text":113,"@type":114},"Elevated arginine and reduced acylcarnitine C18:2 were associated with LUSC diagnosis and prognosis. PC decreased, while LPCs increased in LUSC patients.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did phosphatidylcholine (PC) and lysophosphatidylcholines (LPC) differ between LUSC patients and controls?",{"text":118,"@type":114},"Most PCs showed a decrease in LUSC, whereas lysophosphatidylcholines exhibited an increase. Network analysis indicated LPCs mediated relationships between PC and amino acids in LUSC.",{"name":120,"@type":111,"acceptedAnswer":121},"How were public LUSC data used in the analysis?",{"text":122,"@type":114},"Public LUSC data confirmed associations between gene expression levels of enzymes involved in arginine, PC, and LPC biosynthesis pathways and a 5-year survival outcome in LUSC.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369886,1790224369,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMetabolic profiles of squamous cell lung carcinoma and diagnostic model construction  \nKyung Soo Kim1, Seok Whan Moon1, Mi Hyung Moon1, Seung Joon Kim2, Kwang Youl Kim3,6􀀍 & Dong Wook Jekarl4,5,6􀀍  \nCancer cells exhibit metabolic reprogramming to fulfill their increased demands for abnormal growth and proliferation. We studied metabolic profiles of squamous cell lung carcinoma (LUSC) .  \nElevated arginine levels and reduced acylcarnitine C18:2, along with decreased phosphatidylcholine (PC) with acyl-alkyl residues C38:0 were associated with the diagnosis and prognosis of LUSC. Most of the PCs demonstrated a decrease, while lysophosphatidylcholines (LPC) exhibited an increase in LUSC patients. Network analysis unveiled that LPCs mediated PC and amino acids subgroup in LUSC compared to the control group. Analysis of public LUSC data confirmed associations between the expression levels of genes encoding enzymes involved in the biosynthesis pathways of arginine, proline (ASL, OTC, PYCR2), PC (CEPT1, CHPT1, LPCAT1) and LPC (LCAT, PLA2G16, PLB1) with a 5-yr survival outcome. The observed metabolic reprogramming in LUSC patients suggested the potential utility of metabolites as a supportive biomarkers for LUSC diagnosis.  \nKeywords Metabolic profiles, Lung squamous cell carcinoma, Feature selection, LASSO, Mass spectormetry  \nAbbreviations  \nLUSC Squamous cell lung carcinoma  \nArg arginine  \nC18.2 Acylcarnitine C18:2, C18.2  \nPC Phosphatidylcholine  \n[PC.ae.C38.6](PC.ae.C38.6) PC with acyl alkyl residues C38:6 LPC Lysophosphatidylcholines  \nEA Early stage cancer  \nADV Advanced stage cancer  \nTNM Tumor, Node, Metastasis stages  \nLC Liquid chromatography  \nMS Mass spectrometry  \nTCGA The Cancer Genome Atlas  \nPro Proline  \nGAMboost Gradient boosting for additive models in mboost LASSO Least absolute shrinkage and selection operator SDWD Sparse distance weighted discrimination XGboost Extreme gradient boosting  \nPCA Principal component analysis  \nPLS-DA Partial least squares discriminant analysis ROC Receiver operating characteristic  \nGlu Glutamic acid  \nASL Argininosuccinate lyase  \n1Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 2Department of Pulmonology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 3Department of Clinical Pharmacology, Inha University Hospital, Inha University, 27 Inhang-ro, Jung-gu, Incheon 22332, Republic of Korea. 4Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222, Banpodaero, Seocho-gu, Seoul 06591, Republic of Korea. 5Research and Development Institute for In Vitro Diagnostic Medical Devices, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 6Kwang Youl Kim and Dong Wook Jekarl contributed equally to this work. 􀀍 email: [Kykim@inhauh.com](Kykim@inhauh.com); [bonokarl@catholic.ac.kr](bonokarl@catholic.ac.kr)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nOTC PYCR2 CEPT1  \nCHPT1 LPCAT1 LCATPLA2G16 PLB1  \nOrnithine transcarbamylase Pyrroline-5-carboylate reductase 2  \nCholine/Ethanolamine Phosphotransferase 1 Choline phosphotransferse 1  \n1-acyl-sn-glycoerol-3-phosphate acyltrnsferase Lecithin-cholesterol acyltransferase Phospholipase A and Acyltransferase 3 Phospholipase B1  \nLung carcinoma ranks as the second most prevalent malignancy, trailing behind breast cancer and followed by colorectal, prostate and stomach cancers in global statistics1. However, lung cancer registers the highest mortality rate, surpassing breast, colorectal, and liver cancers in 20201. Among non-small cell lung carcinoma cases, approximately 30% are attributed to squamous cell type (LUSC), while non-squamous cell types constitute about 65%, with the remainde","cbCaijrjDQDv4umX","https://ap.wps.com/l/cbCaijrjDQDv4umX","pdf",3693998,12,"English","# Introduction\n## Lung squamous cell carcinoma background\n## Metabolomics and metabolic demand\n# Metabolic profiling and biomarker findings\n## Arginine and acylcarnitine alterations\n## PC and LPC changes\n## Network analysis and public data validation","[{\"question\":\"Which metabolites were associated with LUSC diagnosis and prognosis?\",\"answer\":\"Elevated arginine and reduced acylcarnitine C18:2 were associated with LUSC diagnosis and prognosis. PC decreased, while LPCs increased in LUSC patients.\"},{\"question\":\"How did phosphatidylcholine (PC) and lysophosphatidylcholines (LPC) differ between LUSC patients and controls?\",\"answer\":\"Most PCs showed a decrease in LUSC, whereas lysophosphatidylcholines exhibited an increase. Network analysis indicated LPCs mediated relationships between PC and amino acids in LUSC.\"},{\"question\":\"How were public LUSC data used in the analysis?\",\"answer\":\"Public LUSC data confirmed associations between gene expression levels of enzymes involved in arginine, PC, and LPC biosynthesis pathways and a 5-year survival outcome in LUSC.\"}]","Metabolic profiles of squamous cell lung carcinoma and diagnostic model construction | PDF",1790185062,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db8712c725c1764d70fa2f0d6feb7a1f.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/710a905fa9b2033f964d42e0a27730c3.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5d7e1c137958be2bade2e65a6f06bbf.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91cbaac97ca59b45b9d717cb3eddac59.webp",980,1287]